HEPATIC FIBROSIS side effect
What is HEPATIC FIBROSIS ?Drugs associated with HEPATIC FIBROSIS
ACETAMINOPHEN ALLOPURINOL APROVEL BAYCOL BYETTA CAMPATH CELLCEPT CLOFARABINE DESFLURANE DICLOFENAC ENBREL FORTAMET GEMCITABINE ISRADIPINE KALETRA KEFLEX LAMIVUDINE LEFLUNOMIDE LEUPROLIDE LEVAQUIN LOMOTIL METHOTREXATE NATALIZUMAB NEVIRAPINE PEGASYS PROGRAF RAPAMUNE RIBAVIRIN TRACLEER TYSABRIHEPATIC FIBROSIS : Leflunomide Side Effects Report #5652175-4
Consumer or non-health professional from FRANCE reported LEFLUNOMIDE problem on Feb 18, 2008. Female patient, 34 years of age, was diagnosed with juvenile arthritis, therapeutic procedure and was treated with LEFLUNOMIDE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic lesion, hepatic necrosis, hepatitis fulminant, hepatomegaly, hepatotoxicity, vitamin k deficiency, . LEFLUNOMIDE dosage: 20 MG/DAY. During the same period patient was treated with CHOLESTYRAMINE, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Acetaminophen Side Effects Report #5688258-2
ACETAMINOPHEN problem was reported by a Health Professional from UNITED KINGDOM on Mar 18, 2008. Female patient was treated with ACETAMINOPHEN. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatocellular injury, overdose, . ACETAMINOPHEN dosage: unknown. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Byetta Side Effects Report #5645019-8
Physician from UNITED STATES reported BYETTA problem on Feb 21, 2008. Male patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, portal hypertension, varices oesophageal, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, ACTOS. Patient recovered.
HEPATIC FIBROSIS : Clofarabine Side Effects Report #5646790-1
CLOFARABINE problem was reported by a Physician from UNITED KINGDOM on Feb 18, 2008. Female patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, pneumonia, . CLOFARABINE dosage: 35 MG, QDX5, INTRAVENOUS. During the same period patient was treated with GLICLAZIDE, METFORMIN, QUINE SULPHATE, ACARBOSE, TIMOLOL MALEATE. Patient died on 01/26/2008.
HEPATIC FIBROSIS : Baycol Side Effects Report #5590945-1
Physician from GERMANY reported BAYCOL problem on Jan 02, 2008. Female patient, 61 years of age, was diagnosed with hypercholesterolaemia and was treated with BAYCOL. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, laboratory test abnormal, muscular weakness, rash, . BAYCOL dosage: unknown. During the same period patient was treated with EXELON, TREVILON RET, GYNODIAN DEP. Patient recovered.
HEPATIC FIBROSIS : Isradipine Side Effects Report #5605693-9
ISRADIPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on Jan 16, 2008. Female patient, 57 years of age, was diagnosed with liver transplant and was treated with ISRADIPINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic steatosis, . ISRADIPINE dosage: 2.5 MG; QD; PO. During the same period patient was treated with NEORAL, COPEGUS, PEGINTERFERON ALFA, OMEPRAZOLE, POTASSIUM CHLORIDE, COZAAR, FUROSEMIDE. Patient recovered.
HEPATIC FIBROSIS : Cellcept Side Effects Report #5563018-1
Physician from GERMANY reported CELLCEPT problem on Dec 04, 2007. Female patient was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . CELLCEPT dosage: UP TO A MAXIMUM DOSE OF 2000MG/DAY. During the same period patient was treated with IMUREK, STEROID NOS, ATGAM, ZENAPAX, INTRON A, REBETOL. Patient recovered.
HEPATIC FIBROSIS : Cellcept Side Effects Report #5563025-9
CELLCEPT problem was reported by a Physician from GERMANY on Dec 04, 2007. Female patient was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . CELLCEPT dosage: UP TO A MAXIMUM DOSE OF 2000MG/DAY. During the same period patient was treated with IMUREK, STEROID NOS, ATGAM, ZENAPAX, INTRON A, REBETOL. Patient recovered.
HEPATIC FIBROSIS : Cellcept Side Effects Report #5563027-2
Physician from GERMANY reported CELLCEPT problem on Dec 04, 2007. Female patient was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . CELLCEPT dosage: UP TO A MAXIMUM DOSE OF 2000MG/DAY. During the same period patient was treated with IMUREK, STEROID NOS, ATGAM, ZENAPAX, INTRON A, REBETOL. Patient recovered.
HEPATIC FIBROSIS : Cellcept Side Effects Report #5563028-4
CELLCEPT problem was reported by a Physician from GERMANY on Dec 04, 2007. Female patient was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . CELLCEPT dosage: UP TO A MAXIMUM DOSE OF 2000MG/DAY. During the same period patient was treated with IMUREK, STEROID NOS, ATGAM, ZENAPAX, INTRON A, REBETOL. Patient recovered.
HEPATIC FIBROSIS : Cellcept Side Effects Report #5563033-8
Physician from GERMANY reported CELLCEPT problem on Dec 04, 2007. Female patient was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . CELLCEPT dosage: UP TO A MAXIMUM DOSE OF 2000MG/DAY. During the same period patient was treated with IMUREK, STEROID NOS, ATGAM, ZENAPAX, INTRON A, REBETOL. Patient recovered.
HEPATIC FIBROSIS : Cellcept Side Effects Report #5563036-3
CELLCEPT problem was reported by a Physician from GERMANY on Dec 04, 2007. Female patient was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . CELLCEPT dosage: UP TO A MAXIMUM DOSE OF 2000MG/DAY. During the same period patient was treated with IMUREK, STEROID NOS, ATGAM, ZENAPAX, INTRON A, REBETOL. Patient recovered.
HEPATIC FIBROSIS : Pegasys Side Effects Report #5570838-6
Physician from UNITED STATES reported PEGASYS problem on Dec 10, 2007. Male patient was diagnosed with hepatitis c virus and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, no therapeutic response, . PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient recovered.
HEPATIC FIBROSIS : Rapamune Side Effects Report #5519446-3
RAPAMUNE problem was reported by a Physician from GERMANY on Nov 12, 2007. Male patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with RAMIPRIL, URSO FALK, PANTOPRAZOLE, CELLCEPT, PREDNISOLONE. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Rapamune Side Effects Report #5526802-6
Physician from GERMANY reported RAPAMUNE problem on Nov 26, 2007. Male patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . RAPAMUNE dosage: unknown. During the same period patient was treated with RAMIPRIL, URSO FALK, PANTOPRAZOLE, CELLCEPT, PREDNISOLONE. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Levaquin Side Effects Report #5474203-1
LEVAQUIN problem was reported by a Physician from UNITED STATES on Sept 28, 2007. Male patient, 49 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic necrosis, hepatitis c, hepatitis c rna positive, hepatotoxicity, liver injury, suicidal ideation, . LEVAQUIN dosage: 500MG/DAY. During the same period patient was treated with LEXAPRO, XANAX, VICODIN. Patient recovered.
HEPATIC FIBROSIS : Gemcitabine Side Effects Report #5402347-9
Physician from UNITED STATES reported GEMCITABINE problem on July 20, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, . GEMCITABINE dosage: unknown. During the same period patient was treated with OXALIPLATIN, CAPECITABINE. Patient recovered.
HEPATIC FIBROSIS : Aprovel Side Effects Report #5400991-6
APROVEL problem was reported by a Physician from FRANCE on July 26, 2007. Female patient, 40 years of age, was diagnosed with hypertension, hiv infection and was treated with APROVEL. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatitis cholestatic, lipodystrophy acquired, lymphopenia, portal hypertension, varices oesophageal, . APROVEL dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR, VIRAMUNE, VIREAD. Patient recovered.
HEPATIC FIBROSIS : Leuprolide Side Effects Report #5404665-7
Consumer or non-health professional from JAPAN reported LEUPROLIDE ACETATE problem on July 27, 2007. Male patient, 73 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic steatosis, obesity, . LEUPROLIDE ACETATE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, LANSOPRAZOLE, ERBANTIL, CERNILTON, CASODEX, PRAVASTATIN, LASIX, UNIPHYL LA. Patient recovered.
HEPATIC FIBROSIS : Aprovel Side Effects Report #5400991-6
APROVEL problem was reported by a Physician from FRANCE on July 26, 2007. Female patient, 40 years of age, was diagnosed with hypertension, hiv infection and was treated with APROVEL. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatitis cholestatic, lipodystrophy acquired, lymphopenia, portal hypertension, varices oesophageal, . APROVEL dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR, VIRAMUNE, VIREAD. Patient recovered.
HEPATIC FIBROSIS : Leuprolide Side Effects Report #5404665-7
Consumer or non-health professional from JAPAN reported LEUPROLIDE ACETATE problem on July 27, 2007. Male patient, 73 years of age, was diagnosed with prostate cancer and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic steatosis, obesity, . LEUPROLIDE ACETATE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, LANSOPRAZOLE, ERBANTIL, CERNILTON, CASODEX, PRAVASTATIN, LASIX, UNIPHYL LA. Patient recovered.
HEPATIC FIBROSIS : Allopurinol Side Effects Report #5676018-8
ALLOPURINOL problem was reported by a Physician from SPAIN on Mar 03, 2008. Female patient, 60 years of age, was diagnosed with hyperuricaemia and was treated with ALLOPURINOL. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic fibrosis, hepatitis, hepatosplenomegaly, nephritis interstitial, renal failure chronic, vasculitis, . ALLOPURINOL dosage: 100 MG TWICE DAILY, ORAL. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Leflunomide Side Effects Report #5676746-4
Physician from FRANCE reported LEFLUNOMIDE problem on Mar 03, 2008. Female patient, 34 years of age, was diagnosed with juvenile arthritis, therapeutic procedure and was treated with LEFLUNOMIDE. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hepatic fibrosis, hepatic necrosis, hepatitis fulminant, hepatomegaly, hepatotoxicity, prothrombin level abnormal, serum ferritin increased, vitamin k deficiency, . LEFLUNOMIDE dosage: 20 MG/DAY. During the same period patient was treated with CHOLESTYRAMINE, ACETAMINOPHEN W, PREDNISONE, NICARDECREASEINE, CANDESARTAN CILEXETIL, CALCIUM CARBONATE, CHOLECALCIFEROL. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Campath Side Effects Report #5625705-6
CAMPATH problem was reported by a Physician from UNITED KINGDOM on Feb 07, 2008. Male patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatic fibrosis, . CAMPATH dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
HEPATIC FIBROSIS : Campath Side Effects Report #5635588-6
Physician from UNITED KINGDOM reported CAMPATH problem on Feb 18, 2008. Male patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatic fibrosis, . CAMPATH dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
HEPATIC FIBROSIS : Campath Side Effects Report #5599609-1
CAMPATH problem was reported by a Physician from UNITED KINGDOM on Jan 08, 2008. Male patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatic fibrosis, . CAMPATH dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
HEPATIC FIBROSIS : Campath Side Effects Report #5600912-7
Physician from UNITED KINGDOM reported CAMPATH problem on Jan 08, 2008. Male patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatic fibrosis, . CAMPATH dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
HEPATIC FIBROSIS : Nevirapine Side Effects Report #5564054-1
NEVIRAPINE problem was reported by a Consumer or non-health professional from on Dec 11, 2007. Male patient, 60 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: gastric varices, hepatic fibrosis, lipodystrophy acquired, liver function test abnormal, oesophageal varices haemorrhage, portal hypertension, splenomegaly, thrombocytopenia, . NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE, ATAZANAVIR. Patient recovered.
HEPATIC FIBROSIS : Nevirapine Side Effects Report #5564055-3
Consumer or non-health professional from reported NEVIRAPINE problem on Dec 11, 2007. Male patient, 35 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: bleeding varicose vein, hepatic fibrosis, hepatosplenomegaly, lipodystrophy acquired, liver function test abnormal, portal hypertension, thrombocytopenia, . NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE, NELFINAVIR. Patient recovered.
HEPATIC FIBROSIS : Nevirapine Side Effects Report #5564056-5
NEVIRAPINE problem was reported by a Consumer or non-health professional from on Dec 11, 2007. Male patient, 50 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: bleeding varicose vein, hepatic fibrosis, liver function test abnormal, portal hypertension, portal vein thrombosis, renal failure, sepsis, thrombocytopenia, . NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE, LOPINAVIR, FAMCICLOVIR. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Campath Side Effects Report #5564578-7
Physician from UNITED KINGDOM reported CAMPATH problem on Dec 12, 2007. Male patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatic fibrosis, . CAMPATH dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
HEPATIC FIBROSIS : Fortamet Side Effects Report #5527422-X
FORTAMET problem was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Male patient, 63 years of age, was treated with FORTAMET. After drug was administered, patient experienced the following problems/side effects: cholangitis, hepatic fibrosis, hepatic necrosis, hepatitis, portal triaditis, . FORTAMET dosage: 500 MG, BID X 4 WEEKS, ORAL. During the same period patient was treated with GLYBURIDE, ALLOPURINOL, ASPIRIN. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Kaletra Side Effects Report #5475253-1
Physician from FRANCE reported KALETRA problem on Sept 25, 2007. Female patient, 52 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic fibrosis, portal hypertension, . KALETRA dosage: unknown. During the same period patient was treated with DIDANOSINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Levaquin Side Effects Report #5491588-0
LEVAQUIN problem was reported by a Physician from UNITED STATES on Oct 19, 2007. Male patient, 37 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform, hepatic fibrosis, hepatitis cholestatic, mobility decreased, speech disorder, weight decreased, . LEVAQUIN dosage: unknown. During the same period patient was treated with URSODIOL, ACCUPRIL. Patient recovered.
HEPATIC FIBROSIS : Keflex Side Effects Report #5469188-8
Physician from UNITED STATES reported KEFLEX problem on Sept 26, 2007. Female patient, 41 years of age, was treated with KEFLEX. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, hepatic fibrosis, hepatic steatosis, hepatitis, liver disorder, lymphocytic infiltration, myopathy, peripheral ischaemia, . KEFLEX dosage: unknown. During the same period patient was treated with OMNICEF. Patient recovered.
HEPATIC FIBROSIS : Kaletra Side Effects Report #5440556-3
KALETRA problem was reported by a Physician from FRANCE on Aug 22, 2007. Female patient was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic fibrosis, portal hypertension, . KALETRA dosage: unknown. During the same period patient was treated with DIDANOSINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
HEPATIC FIBROSIS : Diclofenac Side Effects Report #5392930-1
Physician from JAPAN reported DICLOFENAC problem on July 06, 2007. Female patient was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic fibrosis, hepatic necrosis, hepatitis, liver injury, liver transplant, vanishing bile duct syndrome, . DICLOFENAC dosage: unknown. Patient recovered.
HEPATIC FIBROSIS : Diclofenac Side Effects Report #5392930-1
DICLOFENAC problem was reported by a Physician from JAPAN on July 06, 2007. Female patient was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic fibrosis, hepatic necrosis, hepatitis, liver injury, liver transplant, vanishing bile duct syndrome, . DICLOFENAC dosage: unknown. Patient recovered.
HEPATIC FIBROSIS : Tysabri Side Effects Report #5659998-6
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Feb 20, 2008. Female patient, 50 years of age, weighting 138.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, condition aggravated, hepatic fibrosis, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with SYNTHROID, TAMOXIFEN. Patient recovered.
HEPATIC FIBROSIS : Desflurane Side Effects Report #5622883-X
DESFLURANE problem was reported by a Physician from UNITED STATES on Feb 07, 2008. Female patient, 53 years of age, was treated with DESFLURANE. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic failure, hepatic fibrosis, hepatotoxicity, international normalised ratio increased, liver injury, . DESFLURANE dosage: unknown. During the same period patient was treated with MELLARIL, NEXIUM, PRILOSEC, PROTONIX, BUSPAR, FERROUS SULPHATE. Patient recovered.
HEPATIC FIBROSIS : Lomotil Side Effects Report #5585231-X
Physician from UNITED STATES reported LOMOTIL problem on Jan 08, 2008. Male patient, 28 years of age, was treated with LOMOTIL. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic failure, hepatic fibrosis, hypersexuality, liver injury, . LOMOTIL dosage: unknown. Patient recovered.
HEPATIC FIBROSIS : Enbrel Side Effects Report #5555296-X
ENBREL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Female patient was diagnosed with ankylosing spondylitis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: ankylosing spondylitis, fatigue, hepatic fibrosis, . ENBREL dosage: unknown. Patient recovered.
HEPATIC FIBROSIS : Prograf Side Effects Report #5572346-5
Physician from JAPAN reported PROGRAF problem on Dec 03, 2007. Male patient, 37 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of transplanted liver, condition aggravated, hepatic fibrosis, hepatitis c virus, hepatitis cholestatic, infection, no therapeutic response, . PROGRAF dosage: unknown. Patient recovered.
HEPATIC FIBROSIS : Tracleer Side Effects Report #5574420-6
TRACLEER problem was reported by a Physician from UNITED STATES on Dec 04, 2007. Female patient, 44 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, hepatic fibrosis, . TRACLEER dosage: unknown. Patient died on 01/01/2007.
HEPATIC FIBROSIS : Ribavirin Side Effects Report #5517798-1
Consumer or non-health professional from UNITED STATES reported RIBAVIRIN problem on Nov 04, 2007. Female patient, 50 years of age, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, headache, hepatic fibrosis, migraine, vomiting, white blood cell count decreased, . RIBAVIRIN dosage: unknown. During the same period patient was treated with PEGASYS, ACTANOL, INDERAL. Patient recovered.
HEPATIC FIBROSIS : Lamivudine Side Effects Report #5520889-2
LAMIVUDINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2007. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, chronic hepatitis, hepatic fibrosis, hepatic necrosis, hepatitis c, hepatitis c rna positive, immune reconstitution syndrome, liver disorder, . LAMIVUDINE dosage: unknown. During the same period patient was treated with ABACAVIR, NEVIRAPINE, EFAVIRENZ, RITONAVIR, TENOFOVIR DISOPROXIL FUMARATE, FOSAMPRENAVIR. Patient recovered.
HEPATIC FIBROSIS : Natalizumab Side Effects Report #5527212-8
Physician from UNITED STATES reported NATALIZUMAB problem on Nov 16, 2007. Male patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: back pain, fall, hepatic fibrosis, hepatitis acute, nephrolithiasis, protein total increased, serum ferritin increased, treatment noncompliance, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with SPIRULINA, VITAMIN CAP, PREDNISONE. Patient recovered.
HEPATIC FIBROSIS : Methotrexate Side Effects Report #5485192-8
METHOTREXATE problem was reported by a Pharmacist from UNITED STATES on Oct 10, 2007. Male patient, weighting 187.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic failure, hepatic fibrosis, hepatic siderosis, hepatic steatosis, hyperammonaemia, multi-organ failure, renal impairment, . METHOTREXATE dosage: 420 MG -200 MG/M2- IV. During the same period patient was treated with PEGASPARGASE ENZON, BACTRIM DS, VINCRISTINE, DAUNORUBICIN, CYCLOPHOSPHAMIDE, CYTARABINE, MERCAPTOPURINE. Patient recovered.
HEPATIC FIBROSIS : Tysabri Side Effects Report #5470314-5
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Sept 11, 2007. Male patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, fall, hepatic fibrosis, nephrolithiasis, obstruction, protein total increased, scan abdomen abnormal, serum ferritin increased, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with SPIRULINA, VITAMIN CAP, PREDNISONE. Patient recovered.
HEPATIC FIBROSIS : Gemcitabine Side Effects Report #5409684-2
GEMCITABINE problem was reported by a Physician from UNITED STATES on July 31, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic fibrosis, nausea, vomiting, weight decreased, . GEMCITABINE dosage: 1000 MG/M2, UNK. During the same period patient was treated with OXALIPLATIN, CAPECITABINE. Patient recovered.
HEPATIC FIBROSIS : Prograf Side Effects Report #5414610-6
Physician from UNITED STATES reported PROGRAF problem on July 16, 2007. Male patient, 49 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: ascites, disease recurrence, hepatic fibrosis, hepatitis chronic active, lymphoedema, oedema peripheral, post procedural complication, . PROGRAF dosage: unknown. During the same period patient was treated with INTERFERON, RIBAVIRIN, MYCOPHENOLATE MOFETIL, PREDNISONE, TRIMETOPRIM, GANCICLOVIR. Patient recovered.